217 related articles for article (PubMed ID: 23349794)
1. Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.
Bellucci L; Dalvai M; Kocanova S; Moutahir F; Bystricky K
PLoS One; 2013; 8(1):e54102. PubMed ID: 23349794
[TBL] [Abstract][Full Text] [Related]
2. The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53-binding site of the p21 gene in response to doxorubicin.
Ding J; Yu C; Sui Y; Wang L; Yang Y; Wang F; Yao H; Xing F; Liu H; Li Y; Shah JA; Cai Y; Jin J
FEBS J; 2018 Sep; 285(17):3270-3285. PubMed ID: 30055111
[TBL] [Abstract][Full Text] [Related]
3. p21 transcription is regulated by differential localization of histone H2A.Z.
Gévry N; Chan HM; Laflamme L; Livingston DM; Gaudreau L
Genes Dev; 2007 Aug; 21(15):1869-81. PubMed ID: 17671089
[TBL] [Abstract][Full Text] [Related]
4. Decrease of p400 ATPase complex and loss of H2A.Z within the p21 promoter occur in senescent IMR-90 human fibroblasts.
Lee K; Lau ZZ; Meredith C; Park JH
Mech Ageing Dev; 2012; 133(11-12):686-94. PubMed ID: 23146670
[TBL] [Abstract][Full Text] [Related]
5. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.
Simboeck E; Sawicka A; Zupkovitz G; Senese S; Winter S; Dequiedt F; Ogris E; Di Croce L; Chiocca S; Seiser C
J Biol Chem; 2010 Dec; 285(52):41062-73. PubMed ID: 20952396
[TBL] [Abstract][Full Text] [Related]
6. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
8. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
9. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
[TBL] [Abstract][Full Text] [Related]
10. Insulin-dependent transcriptional control in L6 rat myotubes is associated with modulation of histone acetylation and accumulation of the histone variant H2A.Z in the proximity of the transcriptional start site.
Zerzaihi O; Chriett S; Vidal H; Pirola L
Biochem Cell Biol; 2014 Feb; 92(1):61-7. PubMed ID: 24471919
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
Zhou Q; Dalgard CL; Wynder C; Doughty ML
BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
[TBL] [Abstract][Full Text] [Related]
12. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
13. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter.
Nian H; Delage B; Pinto JT; Dashwood RH
Carcinogenesis; 2008 Sep; 29(9):1816-24. PubMed ID: 18628250
[TBL] [Abstract][Full Text] [Related]
14. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines.
Feng X; Han H; Zou D; Zhou J; Zhou W
Oncotarget; 2017 Jan; 8(2):3364-3379. PubMed ID: 27926517
[TBL] [Abstract][Full Text] [Related]
16. H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression.
Dalvai M; Bellucci L; Fleury L; Lavigne AC; Moutahir F; Bystricky K
Oncogene; 2013 Sep; 32(36):4243-51. PubMed ID: 23108396
[TBL] [Abstract][Full Text] [Related]
17. H2A.Z overexpression promotes cellular proliferation of breast cancer cells.
Svotelis A; Gévry N; Grondin G; Gaudreau L
Cell Cycle; 2010 Jan; 9(2):364-70. PubMed ID: 20023423
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.
Scuto A; Kirschbaum M; Buettner R; Kujawski M; Cermak JM; Atadja P; Jove R
Cell Death Dis; 2013 May; 4(5):e635. PubMed ID: 23681230
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.
Margueron R; Licznar A; Lazennec G; Vignon F; Cavaillès V
J Endocrinol; 2003 Oct; 179(1):41-53. PubMed ID: 14529564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
